Apeiron Investment Group Ltd. - 26 Apr 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role: 10%+ Owner
Signature: Apeiron Investment Group Ltd. By: /s/ Julien Hofer, Director
Issuer symbol: ATAI
Transactions as of: 26 Apr 2022
Net transactions value: +$308,567
Form type: 4
Filing time: 28 Apr 2022, 16:26:56 UTC
Previous filing: 26 Apr 2022
Next filing: 02 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATAI	Common Shares	Purchase	$216,628	+46,207	+2.8%	$4.69	1,722,899	26 Apr 2022	By Apeiron Presight Capital Fund II, L.P.	F1
transaction	ATAI	Common Shares	Purchase	$91,939	+19,803	+1.1%	$4.64	1,742,702	27 Apr 2022	By Apeiron Presight Capital Fund II, L.P.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.58 to $4.80 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.54 to $4.77 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.58 to $4.80 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.54 to $4.77 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.